FINHUB Insights

PODD · Q2 FY25 · Apr 1 – Jun 30, 2025

Insulet Q2 FY25: where the revenue came from and where it went

Insulet Q2 FY25: revenue $0.6B (+33% year over year). Net profit $0B. Largest cohort U.S.Omnipod $0.5B. The whole income statement as a sankey diagram from the SEC filing.

Period
Apr 1 – Jun 30, 2025
Reported
Aug 7, 2025 10-Q
Sankey diagram of Insulet's income statement for Q2 FY25: revenue of $0.6 billion splits into segments and flows out into costs, taxes and net profit.

Tap the diagram to enlarge · figures in billions of dollars

Revenue$0.6B +33% year over year
Gross profit$0.5B 70% margin
Operating profit$0.1B 19% margin
Net profit$0B 3% margin

The numbers

All figures in billions of U.S. dollars, for Q2 FY25 (period ends Jun 30, 2025).
ItemValueShare of revenueYear over year
Revenue 0.6 100% +33%
U.S.Omnipod 0.5 83% +29%
International Omnipod 0.2 33% +45%
Cost of revenue−0.233%
Gross profit0.570% margin+2pp
Research & development−0.111%+0pp
SG&A−0.240%−6pp
Operating profit0.119% margin+7pp
Interest & other costs−0.1
Net profit03%−35pp
Filing on EDGAR More quarters of PODD

Source of the numbers: structured XBRL data from the filing (10-Q). The diagram is generated automatically and checked against EDGAR before release. How we calculate it → About and methodology.

Older quarters